ReviewTrends in cancer2018

Inflammatory Reprogramming with IDO1 Inhibitors: Turning Immunologically Unresponsive 'Cold' Tumors 'Hot'.

George C Prendergast et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.